Crossmark

How many patients with rheumatic diseases and TNF inhibitors treatment have latent tuberculosis?

Crossref DOI link: https://doi.org/10.1016/j.reumae.2016.05.010

Published Print: 2017-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Busquets-Pérez, Noemi

Ponce, Andrés

Ortiz-Santamaria, Vera

de Agustín de Oro, Juanjosé

Hernández-Rico, Yolanda León

Vidal, Imma

Alfonso, Carolina

Argemí, Sonia

Muñoz, Blanca

Quispe, Fernando

Díaz, Ana Carolina

Campos, Salvador

Hernández, Teresa Mariné

Torres, Miquel

Surís, Xavier
License Information

Text and Data Mining valid from 2017-09-01
More Information

This article is maintained by: Elsevier

Article Title: How many patients with rheumatic diseases and TNF inhibitors treatment have latent tuberculosis?

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2016.05.010

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2016.05.006

Content Type: article

Copyright: © 2016 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.